CD68 and prostate carcinoma: Positive; ADT increases the abundance of CD68+ macrophages. This elevated relative abundance of CD68+ cells favored prostate cancer progression and recurrence in control group. No correlations with clinical parameters or recurrence were observed in the ADT group.